Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab.
- 1 December 2001
- journal article
- case report
- Published by Elsevier in Clinical Lymphoma
- Vol. 2 (3), 185-187
- https://doi.org/10.3816/clm.2001.n.025
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- T-Cell-Rich B-Cell Non-Hodgkin's Lymphoma Mimicking Hodgkin's DiseaseLeukemia & Lymphoma, 1999
- T-Cell-Rich B Large-Cell Lymphoma Simulating Lymphocyte-Rich Hodgkin's DiseaseThe American Journal of Surgical Pathology, 1996
- T‐cell rich B‐cell non‐Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's diseaseHistopathology, 1996
- T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.Journal of Clinical Oncology, 1995
- T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?British Journal of Haematology, 1995
- T-Cell-Rich Large B-Cell LymphomaThe American Journal of Surgical Pathology, 1994
- T-Cell-Rich B-Cell LymphomasThe American Journal of Surgical Pathology, 1992
- Histiocyte-Rich B-Cell LymphomaThe American Journal of Surgical Pathology, 1992
- Large B‐cell lymphoma rich in T‐cells and simulating Hodgkin's diseaseHistopathology, 1991
- T-Cell-Rich B-Cell LymphomaThe American Journal of Surgical Pathology, 1988